Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens

Atsushi Suetsugu, Matthew Katz, Jason Fleming, Mark Truty, Ryan Thomas, Shigetoyo Saji, Hisataka Moriwaki, Michael Bouvet, Robert M. Hoffman

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Tumors from pancreatic cancer patients were established in NODISClD mice immediately after surgery and subsequently passaged orthotopically in transgenic nude mice ubiquitously expressing green fluorescent protein (GFP). The primary patient tumors acquired GFP-expressing stroma. Subsequent liver metastases, and disseminated peritoneal metastases maintained the stroma from the primary tumor, and possibly recruited additional GFP-expressing stroma, resulting in their very bright fluorescence. The GFP-expressing stroma included cancer-associated fibroblasts and tumor-associated macrophages in both the primary and metastatic tumors. This imageable model of metastasis from a patient-tumor is an important advance over patient "tumorgraft" models currently in use, which are implanted subcutaneously, do not metastasize and are not imageable. The new imageable model of patient pancreatic cancer metastasis provides unique opportunities to identify current and novel antimetastatic therapeutics for individual patients.

Original languageEnglish (US)
Pages (from-to)1175-1180
Number of pages6
JournalAnticancer Research
Volume32
Issue number4
StatePublished - Apr 1 2012
Externally publishedYes

Fingerprint

Green Fluorescent Proteins
Pancreatic Neoplasms
Neoplasm Metastasis
Neoplasms
Nude Mice
Transgenic Mice
Fluorescence
Macrophages
Liver

Keywords

  • GFP
  • Human-patient pancreatic cancer
  • Imaging
  • Metastasis
  • Microenvironment
  • Nude mice
  • Stroma
  • Tumor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens. / Suetsugu, Atsushi; Katz, Matthew; Fleming, Jason; Truty, Mark; Thomas, Ryan; Saji, Shigetoyo; Moriwaki, Hisataka; Bouvet, Michael; Hoffman, Robert M.

In: Anticancer Research, Vol. 32, No. 4, 01.04.2012, p. 1175-1180.

Research output: Contribution to journalArticle

Suetsugu, A, Katz, M, Fleming, J, Truty, M, Thomas, R, Saji, S, Moriwaki, H, Bouvet, M & Hoffman, RM 2012, 'Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens', Anticancer Research, vol. 32, no. 4, pp. 1175-1180.
Suetsugu, Atsushi ; Katz, Matthew ; Fleming, Jason ; Truty, Mark ; Thomas, Ryan ; Saji, Shigetoyo ; Moriwaki, Hisataka ; Bouvet, Michael ; Hoffman, Robert M. / Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens. In: Anticancer Research. 2012 ; Vol. 32, No. 4. pp. 1175-1180.
@article{06172149b1f34be394ace16f91f29e70,
title = "Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens",
abstract = "Tumors from pancreatic cancer patients were established in NODISClD mice immediately after surgery and subsequently passaged orthotopically in transgenic nude mice ubiquitously expressing green fluorescent protein (GFP). The primary patient tumors acquired GFP-expressing stroma. Subsequent liver metastases, and disseminated peritoneal metastases maintained the stroma from the primary tumor, and possibly recruited additional GFP-expressing stroma, resulting in their very bright fluorescence. The GFP-expressing stroma included cancer-associated fibroblasts and tumor-associated macrophages in both the primary and metastatic tumors. This imageable model of metastasis from a patient-tumor is an important advance over patient {"}tumorgraft{"} models currently in use, which are implanted subcutaneously, do not metastasize and are not imageable. The new imageable model of patient pancreatic cancer metastasis provides unique opportunities to identify current and novel antimetastatic therapeutics for individual patients.",
keywords = "GFP, Human-patient pancreatic cancer, Imaging, Metastasis, Microenvironment, Nude mice, Stroma, Tumor",
author = "Atsushi Suetsugu and Matthew Katz and Jason Fleming and Mark Truty and Ryan Thomas and Shigetoyo Saji and Hisataka Moriwaki and Michael Bouvet and Hoffman, {Robert M.}",
year = "2012",
month = "4",
day = "1",
language = "English (US)",
volume = "32",
pages = "1175--1180",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens

AU - Suetsugu, Atsushi

AU - Katz, Matthew

AU - Fleming, Jason

AU - Truty, Mark

AU - Thomas, Ryan

AU - Saji, Shigetoyo

AU - Moriwaki, Hisataka

AU - Bouvet, Michael

AU - Hoffman, Robert M.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Tumors from pancreatic cancer patients were established in NODISClD mice immediately after surgery and subsequently passaged orthotopically in transgenic nude mice ubiquitously expressing green fluorescent protein (GFP). The primary patient tumors acquired GFP-expressing stroma. Subsequent liver metastases, and disseminated peritoneal metastases maintained the stroma from the primary tumor, and possibly recruited additional GFP-expressing stroma, resulting in their very bright fluorescence. The GFP-expressing stroma included cancer-associated fibroblasts and tumor-associated macrophages in both the primary and metastatic tumors. This imageable model of metastasis from a patient-tumor is an important advance over patient "tumorgraft" models currently in use, which are implanted subcutaneously, do not metastasize and are not imageable. The new imageable model of patient pancreatic cancer metastasis provides unique opportunities to identify current and novel antimetastatic therapeutics for individual patients.

AB - Tumors from pancreatic cancer patients were established in NODISClD mice immediately after surgery and subsequently passaged orthotopically in transgenic nude mice ubiquitously expressing green fluorescent protein (GFP). The primary patient tumors acquired GFP-expressing stroma. Subsequent liver metastases, and disseminated peritoneal metastases maintained the stroma from the primary tumor, and possibly recruited additional GFP-expressing stroma, resulting in their very bright fluorescence. The GFP-expressing stroma included cancer-associated fibroblasts and tumor-associated macrophages in both the primary and metastatic tumors. This imageable model of metastasis from a patient-tumor is an important advance over patient "tumorgraft" models currently in use, which are implanted subcutaneously, do not metastasize and are not imageable. The new imageable model of patient pancreatic cancer metastasis provides unique opportunities to identify current and novel antimetastatic therapeutics for individual patients.

KW - GFP

KW - Human-patient pancreatic cancer

KW - Imaging

KW - Metastasis

KW - Microenvironment

KW - Nude mice

KW - Stroma

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84859952919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859952919&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 1175

EP - 1180

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -